As on 28 Aug 2026
WhiteOak Capital Pharma and Healthcare Fund
EquityNAV
₹ 17.75
CAGR (3 Years)
%
AUM (Cr)
₹ 824.90
Risk
Very High Risk
About WhiteOak Capital Pharma and Healthcare Fund
The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. However, there can be no assurance that the investment objective of the Scheme will be realized.
Breakdown of this Fund
Chemicals
6.53%
Debt Others
6.43%
Healthcare
49.61%
Pharmaceuticals
81.68%
Plastic products
2.74%
T Bills
7.00%